Suppr超能文献

亨廷顿病敲入小鼠模型中的浦肯野细胞功能障碍和丧失。

Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease.

机构信息

Neuroscience Graduate Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Exp Neurol. 2013 Feb;240:96-102. doi: 10.1016/j.expneurol.2012.11.015. Epub 2012 Nov 26.

Abstract

Huntington Disease (HD) is an autosomal dominant neurological disorder characterized by motor, psychiatric and cognitive disturbances. Recent evidence indicates that the viability and function of cerebellar Purkinje cells (PCs) are compromised in an aggressive mouse model of HD. Here we investigate whether this is also the case in the HdhQ200 knock-in mouse model of HD. Using quantitative-real time-PCR and immunofluorescence, we observed a loss of the PC marker and calcium buffer calbindin in 50week-old symptomatic mice. Reductions were also observed in parvalbumin and glutamic acid decarboxylase protein expression, most markedly in the molecular cell layer. Stereological analysis revealed an overall reduction in the PC population in HdhQ200/Q200 mice by nearly 40%, and loose patch electrophysiology of remaining PCs indicated a reduction in firing rate in HD mice compared to control littermates. Taken together, these data demonstrate that PC survival and function are compromised in a mouse model of adult-onset HD and suggest that further experiments should investigate the contribution of PC death and dysfunction to HD-associated motor impairment.

摘要

亨廷顿病(HD)是一种常染色体显性遗传的神经退行性疾病,其特征是运动、精神和认知障碍。最近的证据表明,在一种侵袭性的 HD 小鼠模型中,小脑浦肯野细胞(PCs)的活力和功能受损。在这里,我们研究了这种情况是否也存在于 HD 的 HdhQ200 敲入小鼠模型中。通过定量实时 PCR 和免疫荧光,我们观察到 50 周龄有症状的小鼠中 PC 标志物和钙缓冲剂钙结合蛋白减少。在分子细胞层中,也观察到副甲状腺球蛋白和谷氨酸脱羧酶蛋白表达减少,最为明显。体视学分析显示,HdhQ200/Q200 小鼠的 PC 群体总数减少了近 40%,而剩余 PC 的松散斑电生理学表明,与对照同窝仔鼠相比,HD 小鼠的放电率降低。综上所述,这些数据表明,在成人发病型 HD 的小鼠模型中,PC 的存活和功能受到损害,并表明应进一步进行实验以研究 PC 死亡和功能障碍对与 HD 相关的运动障碍的贡献。

相似文献

1
Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease.
Exp Neurol. 2013 Feb;240:96-102. doi: 10.1016/j.expneurol.2012.11.015. Epub 2012 Nov 26.
2
Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.
Exp Neurol. 2012 Jul;236(1):171-8. doi: 10.1016/j.expneurol.2012.04.015. Epub 2012 May 2.
4
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
7
Neurological abnormalities in a knock-in mouse model of Huntington's disease.
Hum Mol Genet. 2001 Jan 15;10(2):137-44. doi: 10.1093/hmg/10.2.137.
8
Towards a transgenic model of Huntington's disease in a non-human primate.
Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.
10
Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724. Epub 2012 Jul 11.

引用本文的文献

1
Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures.
Mol Syst Biol. 2025 May;21(5):492-522. doi: 10.1038/s44320-025-00096-3. Epub 2025 Apr 1.
3
Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier.
MedComm (2020). 2024 Jul 13;5(7):e638. doi: 10.1002/mco2.638. eCollection 2024 Jul.
5
Cerebellar granule neurons induce Cyclin D1 before the onset of motor symptoms in Huntington's disease mice.
Acta Neuropathol Commun. 2023 Jan 20;11(1):17. doi: 10.1186/s40478-022-01500-x.
6
Channelopathy of small- and intermediate-conductance Ca-activated K channels.
Acta Pharmacol Sin. 2023 Feb;44(2):259-267. doi: 10.1038/s41401-022-00935-1. Epub 2022 Jun 17.
8
Characterization of a Knock-In Mouse Model with a Huntingtin Exon 1 Deletion.
J Huntingtons Dis. 2021;10(4):435-454. doi: 10.3233/JHD-210494.

本文引用的文献

1
Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice.
Neurosci Lett. 2012 May 23;517(1):7-12. doi: 10.1016/j.neulet.2012.03.080.
2
Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.
Exp Neurol. 2012 Jul;236(1):171-8. doi: 10.1016/j.expneurol.2012.04.015. Epub 2012 May 2.
3
Huntington's disease, calcium, and mitochondria.
Biofactors. 2011 May-Jun;37(3):206-18. doi: 10.1002/biof.162. Epub 2011 Jun 14.
4
Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume.
Am J Med Genet A. 2011 Apr;155A(4):815-8. doi: 10.1002/ajmg.a.33911. Epub 2011 Mar 15.
5
Differential electrophysiological changes in striatal output neurons in Huntington's disease.
J Neurosci. 2011 Jan 26;31(4):1170-82. doi: 10.1523/JNEUROSCI.3539-10.2011.
6
Early autophagic response in a novel knock-in model of Huntington disease.
Hum Mol Genet. 2010 Oct 1;19(19):3702-20. doi: 10.1093/hmg/ddq285. Epub 2010 Jul 8.
7
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease.
Hum Mol Genet. 2010 Sep 1;19(17):3354-71. doi: 10.1093/hmg/ddq247. Epub 2010 Jun 17.
8
Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.
J Neurosci. 2010 May 26;30(21):7227-35. doi: 10.1523/JNEUROSCI.0698-10.2010.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验